Henry Schein forecast annual profit below Wall Street estimates on Tuesday as the dental and medical products distributor faces tepid demand amid persistent inflation.

Charles R. Goulding and Preeti Sulibhavi explain how KKR’s investment in Henry Schein signals a transformative shift in ...

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the fourth quarter and ...

ICICI Securities recommended hold rating on HealthCare Global Enterprises with a target price of Rs 525 in its research ...

Discover why KKR Real Estate Finance offers value with a 9% dividend yield, 24% discount to book value, and growth-focused ...

HealthCare Global share price has risen by over 2% in the past month and more than 5% on a year-to-date (YTD) basis. The ...

KKR has agreed to acquire a majority stake in Healthcare Global Enterprises, an India-based oncology hospital chain, for $400 million. The seller is CVC Capital Partners. Dr. BS Ajaikumar, founder of ...

Rumors of cuts to Medicare Advantage and a new Justice Department probe of UnitedHealth have investors focused on the wrong ...

Private equity firm KKR has agreed to acquire a controlling stake in oncology hospital chain Healthcare Global ...

Domestic equity benchmarks continued their losing streak for the fifth straight day on Monday, taking cues from Wall Streets sharp decline on Friday. The sell-off in U.S. equities was driven by fears ...

India's hospital sector is experiencing a surge in deal-making, with KKR acquiring Healthcare Global for $400 million. This ...

As part of the deal, KKR will purchase up to 54 per cent of HCG's equity from CVC Asia V at a price of INR 445 per share.